Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Management Neutral

nDatalyze Corp. Announces Appointment of Commercial Sales Director for the Epitome Hockey Platform.

RTO Execution Risks Loom Over Tech Commercialization Hopes

Executive Summary
  • nDatalyze Corp. appointed Nicholas Domitrovic as Commercial Sales Director for its Epitome hockey performance platform on April 27, 2026.
  • The company is finalizing terms and conditions for a definitive agreement regarding its previously announced reverse takeover (RTO) transaction.
  • Shareholders are entitled to receive shares of the private Epitome entity being spun out upon closing of the RTO.
  • This follows a March 11, 2026 update where an RTO with PRISM Diversified Ltd. (a mining company) was detailed, including $2M financing and a target agreement date of March 31, 2026.
  • The April 27 announcement comes after the missed March 31 deadline for definitive agreement execution noted in previous releases.
Material Impact
  • Appointment: Hiring a Commercial Sales Director is incremental progress for commercialization but does not guarantee revenue or market traction immediately. It is expected given the prior commercialization report finalized in March.
  • RTO Status: The RTO remains "finalizing" as of April 27, missing the March 31 deadline set on March 11. This indicates execution risk and potential delays, which aligns with the stock price decline from $0.20 to $0.06 since mid-March.
  • Structure Ambiguity: There is a discrepancy between previous news (RTO with PRISM Mining resulting in combined issuer) and recent news (spinning out private Epitome entity). If shareholders receive shares of a private entity, liquidity may be compromised compared to the public listing previously implied. This ambiguity creates uncertainty regarding shareholder value retention.
  • Market Reaction: The stock has consolidated around $0.06-$0.09 since the March peak, suggesting the market is pricing in skepticism regarding the RTO completion and potential dilution or structural changes.
NDAT · Price
Company Overview
  • Company: nDatalyze Corp. (CSE: NDAT).
  • Flagship Project: Epitome Hockey Platform. An AI-driven sports performance analytics platform integrating machine learning, genomics-informed inputs, and proprietary emotional/environmental assessments to generate athlete "Signatures".
  • Development Status: Completed multi-team data collection and calibration across three hockey teams (WHL/OUA) in December 2025. Commercialization report finalized in March 2026 with input from ALPS Hockey Academy and others.
  • Business Model: B2B sales to hockey academies, schools, junior league teams, scouts, and JV partners. Pricing strategy defined but revenue generation not yet materialized in public filings.
Read the original news release →

More from nDatalyze Corp.